BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23836451)

  • 1. Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a 1H and 13C MRS study.
    Stephenson MC; Leverton E; Khoo EY; Poucher SM; Johansson L; Lockton JA; Eriksson JW; Mansell P; Morris PG; MacDonald IA
    NMR Biomed; 2013 Nov; 26(11):1518-26. PubMed ID: 23836451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological and physiological test-retest reliability of (13) C-MRS glycogen measurements in liver and in skeletal muscle of patients with type 1 diabetes and matched healthy controls.
    Buehler T; Bally L; Dokumaci AS; Stettler C; Boesch C
    NMR Biomed; 2016 Jun; 29(6):796-805. PubMed ID: 27074205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal hepatic glycogen storage after fasting and feeding in children and adolescents with type 1 diabetes.
    Flück CE; Slotboom J; Nuoffer JM; Kreis R; Boesch C; Mullis PE
    Pediatr Diabetes; 2003 Jun; 4(2):70-6. PubMed ID: 14655262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle type dependent increase in intramyocellular lipids during prolonged fasting of human subjects: a proton MRS study.
    Wietek BM; Machann J; Mader I; Thamer C; Häring HU; Claussen CD; Stumvoll M; Schick F
    Horm Metab Res; 2004 Sep; 36(9):639-44. PubMed ID: 15486816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects.
    Carey PE; Halliday J; Snaar JE; Morris PG; Taylor R
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E688-94. PubMed ID: 12453829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular glycogen and intramyocellular lipid utilization during prolonged exercise and recovery in man: a 13C and 1H nuclear magnetic resonance spectroscopy study.
    Krssak M; Petersen KF; Bergeron R; Price T; Laurent D; Rothman DL; Roden M; Shulman GI
    J Clin Endocrinol Metab; 2000 Feb; 85(2):748-54. PubMed ID: 10690886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy shows an inverse correlation between intramyocellular lipid content in human calf muscle and local glycogen synthesis rate.
    van der Graaf M; Tack CJ; de Haan JH; Klomp DW; Heerschap A
    NMR Biomed; 2010 Feb; 23(2):133-41. PubMed ID: 19739109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle glycogen content in type 2 diabetes mellitus.
    He J; Kelley DE
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E1002-7. PubMed ID: 15251866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary glycemic index influences lipid oxidation but not muscle or liver glycogen oxidation during exercise.
    Stevenson EJ; Thelwall PE; Thomas K; Smith F; Brand-Miller J; Trenell MI
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1140-7. PubMed ID: 19223653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
    Cline GW; Petersen KF; Krssak M; Shen J; Hundal RS; Trajanoski Z; Inzucchi S; Dresner A; Rothman DL; Shulman GI
    N Engl J Med; 1999 Jul; 341(4):240-6. PubMed ID: 10413736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal variation in skeletal muscle and liver glycogen in humans with normal health and Type 2 diabetes.
    Macauley M; Smith FE; Thelwall PE; Hollingsworth KG; Taylor R
    Clin Sci (Lond); 2015 May; 128(10):707-13. PubMed ID: 25583442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹³C MRS reveals a small diurnal variation in the glycogen content of human thigh muscle.
    Takahashi H; Kamei A; Osawa T; Kawahara T; Takizawa O; Maruyama K
    NMR Biomed; 2015 Jun; 28(6):650-5. PubMed ID: 25881007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In-vivo 1H-MR spectroscopy: the determination of the intra- and extramyocellular lipid content depending on the insulin effect in the direct offspring of type-2 diabetics].
    Brechtel K; Machann J; Jacob S; Strempfer A; Schick F; Häring HU; Claussen CD
    Rofo; 1999 Aug; 171(2):113-20. PubMed ID: 10506884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
    Baker DJ; Greenhaff PL; MacInnes A; Timmons JA
    Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content.
    van Werven JR; Hoogduin JM; Nederveen AJ; van Vliet AA; Wajs E; Vandenberk P; Stroes ES; Stoker J
    J Magn Reson Imaging; 2009 Aug; 30(2):444-8. PubMed ID: 19629974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.
    Ravikumar B; Carey PE; Snaar JE; Deelchand DK; Cook DB; Neely RD; English PT; Firbank MJ; Morris PG; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E789-97. PubMed ID: 15572652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls.
    Bally L; Buehler T; Dokumaci AS; Boesch C; Stettler C
    Diabetes Res Clin Pract; 2015 Jul; 109(1):e1-3. PubMed ID: 26013568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of liver glycogen synthesis in diabetic patients using carbon-13 MR spectroscopy.
    Tomiyasu M; Obata T; Nishi Y; Nakamoto H; Nonaka H; Takayama Y; Autio J; Ikehira H; Kanno I
    Eur J Radiol; 2010 Feb; 73(2):300-4. PubMed ID: 19058940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes.
    De Feyter HM; Lenaers E; Houten SM; Schrauwen P; Hesselink MK; Wanders RJ; Nicolay K; Prompers JJ
    FASEB J; 2008 Nov; 22(11):3947-55. PubMed ID: 18653763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.